Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-02, Stock:JNJ, The news for the past five days is as follows:
2018-04-25: NEWS1: J&J Gets Court to Throw Out $151 Million Artificial Hip Verdict.NEWS2: Buy the Post-Earnings Lull from Johnson & Johnson.NEWS3: Buy the Post-Earnings Lull from Johnson & Johnson.NEWS4: Johnson & Johnson’s Revenue at $20 Billion in 1Q18.NEWS5: Drug Stock Q1 Earnings Due on Apr 26: ABBV, ALXN, BMY & VRTX.NEWS6: Drug Stock Q1 Earnings Due on Apr 26: ABBV, ALXN, BMY & VRTX.NEWS7: Buy the Post-Earnings Lull from Johnson & Johnson.NEWS8: Novartis Launches FocalView to Modernize Clinical Trials.NEWS9: Amgen’s Earnings Grow 12% Year-Over-Year in 1Q18.NEWS10: How Analysts Rate Bristol-Myers Squibb in 1Q18.NEWS11: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS12: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS13: Should OShares FTSE U.S. Quality Dividend ETF (OUSA) Be on Your Investing Radar?.NEWS14: Should OShares FTSE U.S. Quality Dividend ETF (OUSA) Be on Your Investing Radar?.NEWS15: How Did Johnson & Johnson’s Consumer Segment Perform in 1Q18?.NEWS16: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS17: What Do Analysts Predict for Bristol-Myers Squibb in 1Q18?.NEWS18: How Johnson & Johnson’s Medical Devices Segment Performed in 1Q18.
2018-04-26: NEWS1: Abbvie Up over 6% on 1Q18 Earnings Beat, Raised Earnings Forecast.NEWS2: AbbVie (ABBV) Q1 Earnings Beat, 2018 View Up, Stock Gains.NEWS3: AbbVie (ABBV) Q1 Earnings Beat, 2018 View Up, Stock Gains.NEWS4: Daily Dividend Report: JNJ, XOM, POR, CVX, LMT.NEWS5: Daily Dividend Report: JNJ, XOM, POR, CVX, LMT.NEWS6: Bristol-Myers (BMY) Beats on Q1 Earnings, Opdivo Impresses.NEWS7: Bristol-Myers (BMY) Beats on Q1 Earnings, Opdivo Impresses.NEWS8: Notable ETF Outflow Detected - IWB, JPM, JNJ, UNH.NEWS9: Notable ETF Outflow Detected - IWB, JPM, JNJ, UNH.NEWS10: How Analysts Rate JNJ after 1Q18 Earnings.NEWS11: Johnson & Johnson Announces Dividend Increase of 7.1%.NEWS12: Bristol-Myers (BMY) Beats on Q1 Earnings, Opdivo Impresses.NEWS13: Bristol-Myers Squibb’s 1Q18 Earnings Beat Wall Street Estimates.NEWS14: Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?.NEWS15: Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?.NEWS16: What’s Johnson & Johnson’s Valuation after 1Q18 Earnings?.NEWS17: What Wall Street Analysts Estimate for Johnson & Johnson.NEWS18: Johnson & Johnson wins appeal to overturn $151 million hip implant verdict.NEWS19: J&J wins appeal to overturn $151 million hip implant verdict.
2018-04-27: NEWS1: Biotech Stocks Facing FDA Decision In May.NEWS2: Biotech Stocks Facing FDA Decision In May.NEWS3: GlaxoSmithKline’s 1Q18 Earnings: Performance by Segment.NEWS4: Vertex (VRTX) Q1 Earnings Beat on Strong CF Products Sales.NEWS5: Vertex (VRTX) Q1 Earnings Beat on Strong CF Products Sales.NEWS6: Allergan’s 1Q18 Estimates: Expect Growth in Revenues.NEWS7: Daily Chatter: Trillion Dollar Babies.
2018-04-30: NEWS1: 8 Dividend Aristocrats That Also Offer Stock Price Growth.NEWS2: 8 Dividend Aristocrats That Also Offer Stock Price Growth.NEWS3: Exxon Mobil Corporation Leads 6 Dividend Stocks Boosting Payouts.NEWS4: Exxon Mobil Corporation Leads 6 Dividend Stocks Boosting Payouts.NEWS5: 3 Top Value Stocks to Buy Right Now.NEWS6: 3 Top Value Stocks to Buy Right Now.NEWS7: Johnson & Johnson Facing 3 Important Risks in Coming Year.NEWS8: Johnson & Johnson Facing 3 Important Risks in Coming Year.NEWS9: 3 Top Value Stocks to Buy Right Now.NEWS10: Ramp Up In Opdivo And Eliquis Sales Bolsters Bristol-Myers Squibb's Q1 Earnings.NEWS11: Ramp Up In Opdivo And Eliquis Sales Bolsters Bristol-Myers Squibb's Q1 Earnings.NEWS12: Why Analysts Expect Pfizer to See Revenue Growth in 1Q18.NEWS13: Is Fidelity Dividend ETF for Rising Rates (FDRR) a Hot ETF Right Now?.NEWS14: Is Fidelity Dividend ETF for Rising Rates (FDRR) a Hot ETF Right Now?.NEWS15: What Analysts Expect for Pfizer in 1Q18.NEWS16: Eliquis and Xeljanz: Key Growth Drivers for Pfizer in 2018.NEWS17: Cytori Updates On US Manufacturing And EU Approval Plans For ATI-0918.NEWS18: Cytori Updates On US Manufacturing And EU Approval Plans For ATI-0918.
2018-05-01: NEWS1: Pfizer Reports 1Q18 Earnings and Revenue Growth.NEWS2: Merck & Co.’s 1Q18 Earnings: Revenues up 6%.NEWS3: Merck (MRK) Beats on Q1 Earnings, Lags Sales, Raises Outlook.NEWS4: Merck (MRK) Beats on Q1 Earnings, Lags Sales, Raises Outlook.NEWS5: Pfizer (PFE) Stock Falls on Q1 Sales Miss, Earnings Beat.NEWS6: Pfizer (PFE) Stock Falls on Q1 Sales Miss, Earnings Beat.NEWS7: 3 Dividend Stocks That Are Minting Money.NEWS8: 3 Dividend Stocks That Are Minting Money.NEWS9: 3 Dividend Stocks That Are Minting Money.

Answer: Decrease